Author's posts
Adventist restructures leadership as chief strategy officer resigns
Adventist Health recently announced a restructuring of its senior leadership, in a move it said is meant to further support its associates, mission and 2030 transformation strategy.
Omicron, rising expenses will prove challenging for hospitals in 2022
Hospitals and health systems across the country closed 2021 dealing with both rising volumes and ballooning expenses, as COVID-19 cases climbed to new heights, causing critical labor shortages and supply chain issues.
Charles Berg to join Cigna, lead its Medicare Advantage expansion
Cigna has announced that longtime healthcare executive Charles “Chuck” Berg has joined the company as president of its U.S. Government Business and Senior Advisor, a role that will task him with guiding the expansion of Cigna’s Medicare Advantage and I…
Most physicians paid based on volume, not value, Rand finds
Despite efforts by insurance companies and other payers to move toward compensating physicians based on the quality and value of care they provide, most physicians employed in group practices owned by health systems are paid primarily based on the volu…
Medicare Advantage receiving bipartisan support in House of Representatives
More than 340 members of the U.S. House of Representatives, led by Reps.
14.5 million Americans sign up for coverage during open enrollment
A record 14.5 million people have signed up for 2022 health care coverage through the federal Affordable Care Act marketplaces during the most recent open enrollment period from November 1, 2021 to January 15, the Centers for Medicare and Medicaid Serv…
AHIP weighs in on benefit, payment parameters for individual market
In what AHIP calls a push to ensure affordable and quality choices in the federal health insurance marketplaces, the organization for insurers has submitted comments in response to the Department of Health and Human Services’ Notice of Benefit and Paym…
Cleveland Clinic putting more than $1.3B into new capital projects
In an annual State of Clinic address this week, Cleveland Clinic President and CEO Dr. Tom Mihaljevic said the nonprofit academic medical center will be investing about $1.3 billion in capital projects this year, including new hospitals, buildings and …
Due to Omicron, FDA limiting use of COVID-19 antibody treatments
The U.S. Food and Drug Administration has subtracted a pair of COVID-19 monoclonal antibody treatments from the approved list due to what the agency has deemed “ineffectiveness” against the Omicron variant, which has spread rapidly throughout the U.S. …
American Geriatrics Society expresses misgivings about FDA-approved Alheimer’s drug
On January 11, the Centers for Medicare and Medicaid Services announced a proposal to cover Food and Drug Administration-approved monoclonal antibodies directed against amyloid for the treatment of Alzheimer’s disease, including aducanumab, under Cover…
